Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-815-6 | CAS number: 88-26-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 - 27 Oct 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- / GLP guideline study with minor deviations (no medium exchange before overnight incubation of the insert (Preparation of EpiOcularTM Tissues for Treatment), no demonstration of technical proficiency)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 28 July 2015
- Deviations:
- yes
- Remarks:
- / GLP guideline study with minor deviations (no medium exchange before overnight incubation of the insert (Preparation of EpiOcularTM Tissues for Treatment), no demonstration of technical proficiency)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- OGYÉI, Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet, Budapest, Hungary
Test material
- Reference substance name:
- 3,5-di-tert-butyl-4-hydroxybenzyl alcohol
- EC Number:
- 201-815-6
- EC Name:
- 3,5-di-tert-butyl-4-hydroxybenzyl alcohol
- Cas Number:
- 88-26-6
- Molecular formula:
- C15H24O2
- IUPAC Name:
- 2,6-Di-tert-butyl-4-(hydroxymethyl)phenol
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature, dry conditions. Protect from heat and direct sunlight
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability
The EpiOcularTM Eye Irritation Test (EIT) was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and Cosmetics Europe. It was concluded that the EpiOcularTM
EIT is able to correctly identify chemicals not requiring classification and labelling for eye irritation or serious eye damage according to UN GHS, and the test method was recommended as scientifically valid for that purpose.
In order to distinguish between Category 1 (corrosive to eye) and Category 2 (eye irritant), further testing is required.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live
The EpiOcularTM human cell construct (OCL-200-EIT, MatTek Corporation) is used in this assay. It is composed of stratified human keratinocytes in a three-dimensional structure, consisting of at least three viable layers of cells. All biological components of the EpiOcularTM tissue and the kit culture medium have been tested and are free of the presence of viruses, bacteria and mycoplasma.
Analysis for tissue functionality and quality was performed and passed.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 mg - Duration of treatment / exposure:
- 6 h ± 15 min
- Duration of post- treatment incubation (in vitro):
- 25 ± 2 min (Post-exposure immersion incubation)
18 h ± 15 min (Post-treatment incubation) - Number of animals or in vitro replicates:
- 2 replicates
- Details on study design:
- - Details of the test procedure used
The cytotoxicity of the test item (and thus the ocular irritation potential) is evaluated by the relative viability of the treated RhCE tissues in comparison to the negative control-treated tissues. Viability is determined by the NAD(P)H-dependent microsomal enzyme reduction of MTT in control and test item treated cultures.
- RhCE tissue construct used, including batch number
The EpiOcularTM human cell construct (OCL-200-EIT, MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia, Lot number: 23742)
- Doses of test chemical and control substances used
50 mg test item; 50 μL positive control (methyl acetate) and 50 μL negative control (sterile deionized water)
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods
exposure: 6 h ± 15 min at 37 ± 1 °C
post-exposure immersion: 25 ± 2 min at room temperature
post-exposure incubation: 18 h ± 15 min at 37 ± 1 °C
- Description of any modifications to the test procedure
The inserts were transferred aseptically into the 6-well plates and incubated at standard culture conditions directly overnight (37 ± 1°C in an incubator with 5 ± 1% CO2, 90 ± 10% humidified atmosphere) instead of firstly for 1 h, after which the medium should have been exchanged by fresh medium and incubated then overnight.
- Number of tissue replicates used per test chemical and controls
2 replicates each
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer)
570 nm
- Description of the method used to quantify MTT formazan
Inserts were removed from the 24-well plate after the incubation time inn MTT solution (3 h ± 10 min), the bottom of the insert was blotted on absorbent material and transferred to a 6-well plate containing 2 mL isopropanol per well in a manner avoiding the isopropanol to flow into the insert. The plate was sealed with parafilm. To extract the MTT, the plates were placed on an orbital plate shaker and shaken (150 rpm) for ~2 h at room temperature. 200 μL samples from each tube were placed into the wells of a 96-well plate and the absorbance /optical density was measured in a 96-well plate spectrophotometer to determine cell. viability.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model
The test item requires classification and labelling according to UN GHS (Category 2 or Category 1), if the mean percent tissue viability after exposure and post-exposure incubation is ≤ 60% of the negative control.
The test item requires no classification and labelling according to UN GHS (No Category), if the mean percent tissue viability after exposure and post-exposure incubation is > 60%.
- Reference to historical positive and negative control results demonstrating suitable run acceptance criteria
The results obtained for the respective negative and positive controls are in the range of the historical control data.
- Complete supporting information for the specific RhCE tissue construct used
A copy of the test kit quality control sheet and of the certificate of analysis provided by the manufacturer are included in the study report.
- Reference to historical data of the RhCE tissue construct
yes, no further information available
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals
no information provided
- Positive and negative control means and acceptance ranges based on historical data
negative control mean OD: 2.237, range: 2.060 - 2.378
positive control mean OD: 0.229, range: 0.064 - 0.500
- Acceptable variability between tissue replicates for positive and negative controls
Acceptable variability between tissue replicates for positive and negative controls < 20%.
- Acceptable variability between tissue replicates for the test chemical
Acceptable variability between tissue replicates for the test chemical < 20%.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- other: mean viability (%)
- Run / experiment:
- negative control
- Value:
- 100
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- other: mean viability (%)
- Run / experiment:
- positive control
- Value:
- 4
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- other: mean viability (%)
- Run / experiment:
- test item
- Value:
- 93
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: no information provided
DEMONSTRATION OF TECHNICAL PROFICIENCY: no information provided
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, as the mean OD value (2.115) of the two negative control tissues lies between 0.8 and 2.5.
- Acceptance criteria met for positive control: Yes, as the mean percentage viability for the positive control (4%) lies below 50% of the control viability.
Any other information on results incl. tables
Table 1: MTT results of eye irritation study
Controls |
|
Optical Density (OD) |
Viability (%) |
Δ% |
Negative Control: Sterile deionized water |
1 |
2.06 |
97 |
5 |
2 |
2.17 |
103 |
||
mean |
2.115 |
100 |
- |
|
Positive Control: Methyl acetate |
1 |
0.064 |
3 |
1 |
2 |
0.086 |
4 |
||
mean |
0.075 |
4 |
- |
|
Test item |
1 |
2.063 |
98 |
10 |
2 |
1.855 |
88 |
||
mean |
1.959 |
93 |
- |
|
standard deviation (SD) |
6.95 |
- |
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/ EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.